BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 11336676)

  • 1. Crystal structure of a SIR2 homolog-NAD complex.
    Min J; Landry J; Sternglanz R; Xu RM
    Cell; 2001 Apr; 105(2):269-79. PubMed ID: 11336676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the histone deacetylase SIRT2.
    Finnin MS; Donigian JR; Pavletich NP
    Nat Struct Biol; 2001 Jul; 8(7):621-5. PubMed ID: 11427894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions.
    Sauve AA; Celic I; Avalos J; Deng H; Boeke JD; Schramm VL
    Biochemistry; 2001 Dec; 40(51):15456-63. PubMed ID: 11747420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of Alba, a conserved archaeal chromatin protein, with Sir2 and its regulation by acetylation.
    Bell SD; Botting CH; Wardleworth BN; Jackson SP; White MF
    Science; 2002 Apr; 296(5565):148-51. PubMed ID: 11935028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIR2 family of NAD(+)-dependent protein deacetylases.
    Smith JS; Avalos J; Celic I; Muhammad S; Wolberger C; Boeke JD
    Methods Enzymol; 2002; 353():282-300. PubMed ID: 12078503
    [No Abstract]   [Full Text] [Related]  

  • 6. Structural basis for the NAD-dependent deacetylase mechanism of Sir2.
    Chang JH; Kim HC; Hwang KY; Lee JW; Jackson SP; Bell SD; Cho Y
    J Biol Chem; 2002 Sep; 277(37):34489-98. PubMed ID: 12091395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of a Sir2 enzyme bound to an acetylated p53 peptide.
    Avalos JL; Celic I; Muhammad S; Cosgrove MS; Boeke JD; Wolberger C
    Mol Cell; 2002 Sep; 10(3):523-35. PubMed ID: 12408821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry.
    Sauve AA; Schramm VL
    Biochemistry; 2003 Aug; 42(31):9249-56. PubMed ID: 12899610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.
    Avalos JL; Bever KM; Wolberger C
    Mol Cell; 2005 Mar; 17(6):855-68. PubMed ID: 15780941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.
    Imai S; Armstrong CM; Kaeberlein M; Guarente L
    Nature; 2000 Feb; 403(6771):795-800. PubMed ID: 10693811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
    Borra MT; Langer MR; Slama JT; Denu JM
    Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates.
    Sauve AA; Schramm VL
    Curr Med Chem; 2004 Apr; 11(7):807-26. PubMed ID: 15078167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases.
    Zhao K; Harshaw R; Chai X; Marmorstein R
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8563-8. PubMed ID: 15150415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of substrate analogs and mutagenesis to study substrate binding and catalysis in the Sir2 family of NAD-dependent protein deacetylases.
    Khan AN; Lewis PN
    J Biol Chem; 2006 Apr; 281(17):11702-11. PubMed ID: 16520376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2: Evidence for acetyl transfer from substrate to an NAD breakdown product.
    Tanny JC; Moazed D
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):415-20. PubMed ID: 11134535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae.
    Lin SJ; Defossez PA; Guarente L
    Science; 2000 Sep; 289(5487):2126-8. PubMed ID: 11000115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene silencing: two faces of SIR2.
    Gottschling DE
    Curr Biol; 2000 Oct; 10(19):R708-11. PubMed ID: 11050406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Sir2 and the 'silencing' of p53 activity.
    Smith J
    Trends Cell Biol; 2002 Sep; 12(9):404-6. PubMed ID: 12220851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of NAD(+) in the deacetylase activity of the SIR2-like proteins.
    Landry J; Slama JT; Sternglanz R
    Biochem Biophys Res Commun; 2000 Nov; 278(3):685-90. PubMed ID: 11095969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural identification of 2'- and 3'-O-acetyl-ADP-ribose as novel metabolites derived from the Sir2 family of beta -NAD+-dependent histone/protein deacetylases.
    Jackson MD; Denu JM
    J Biol Chem; 2002 May; 277(21):18535-44. PubMed ID: 11893743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.